A large global life sciences company needed support in developing a product launch operating model that would enable the delivery of several key therapies to market over the next three years. Our experts partnered with their team to help provide clarity on roles and responsibilities, ways of working, and behaviors that would make future product launches effective.

A global Life Sciences company was set to launch a new oncology drug in the US market without a formal team or strategy in place a year before the anticipated FDA approval. By engaging with our experts, we helped to establish a diverse launch team across 15+ functional areas and develop the tools and governance needed for efficient and repeated successful launches in the future.

A life sciences company specializing in molecular diagnostics faced an unparalleled challenge: facilitating the rapid development, authorization and launch of a point-of-care COVID-19 testing system. With the help of our product launch experts, the test was shipped less than 10 days after FDA authorisation to hospitals across the US.

A leading global pharmaceutical company had developed a promising treatment for Ulcerative Colitis but needed to understand the product’s potential in the US market to maximize its commercial impact. Our experts developed a contracting strategy comparing standalone versus portfolio offerings, produced detailed financial modelling, and delivered a full suite of HEOR launch materials to demonstrate cost-effectiveness for payers.